glp-1 treatment nyc GLP1 weight loss doctor Researchers find GLP-1 medications safe
Description
In separate trials, tirzepatide 15 mg produced 20.9% average weight loss compared to semaglutide 2.4 mg at 14.9%
Results showed a mean apnea-hypopnea index (AHI) reduction of up to 63% (about 30 fewer events per hour)
When to consider GLP-1 microdosing Based on current clinical practice patterns, practitioners are most commonly recommending GLP-1 microdosing in these scenarios: Partial responders: Patients on standard therapy who have improved but still experience breakthrough flares, residual inflammation, or persistent symptoms
A Sharps Container: This is an FDA-cleared container for safely disposing of used needles and syringes
